Xenothera is a clinical-stage biotech company specializing in therapeutic for immunological treatments. It develops approaches in immunotherapy utilizing glyco-humanized polyclonal antibodies (GH-pAb). The company operates in domains including immunology, oncology, viral infections, and others.